4/A//SEC Filing
Reynoso Jamie L. 4/A
Accession 0001839066-25-000006
CIK 0001801170other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:59 PM ET
Size
6.4 KB
Accession
0001839066-25-000006
Insider Transaction Report
Form 4/AAmended
Reynoso Jamie L.
CEO, Medicare Advantage
Transactions
- Tax Payment
Class A Common Stock
2024-06-30$1.23/sh−52,967$65,149→ 2,401,108 total
Footnotes (3)
- [F1]This Form 4/A is being filed to solely to clarify that the total number of restricted stock units (RSUs) received upon determination of the level of performance-based RSU grant was previously reported by the Reporting Person on a Form 4/A, filed on January 3, 2024, as described in Footnote 2 below.
- [F2]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the second tranche of the number of earned restricted stock units, as described herein. Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested on September 7, 2023, one-third of the number of earned restricted stock units vested on June 30, 2024, and the remaining one-third of the earned restricted stock units vested on June 30, 2025.
- [F3]Number reflects total directly held Class A Common Stock taking into account the amended number and transactions through June 30, 2024.
Documents
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
CIK 0001801170
Entity typeother
Related Parties
1- filerCIK 0001839066
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:59 PM ET
- Size
- 6.4 KB